期刊文献+

PTEN基因在人和树鼠句肝细胞癌组织中低表达 被引量:4

Low expression of gene PTEN in human and tree shrew heptocellular carcinoma
下载PDF
导出
摘要 目的:研究人和树鼠句肝癌和癌旁组织中PTEN基因的表达情况以及与肝癌侵袭转移的关系。方法:用RT-PCR和免疫组织化学方法分别检测人肝癌、癌旁组织和正常组织以及树鼠句肝癌和癌旁组织中PTEN mRNA和PTEN蛋白的表达情况。结果:PTEN mRNA在人的正常组织、癌旁组织、肝癌组织中的表达依次降低,差异有统计学意义,t值分别为-0.955和-10.065,P值均<0.001;树鼠句肝癌组织中PTEN mRNA的表达显著低于癌旁组织中的表达,t=-3.25,P=0.004。PTEN蛋白的表达在人的癌旁组织显著高于肝癌组织,t=-2.163,P=0.038;在树鼠句则无差别,t=0.757,P=0.459。结论:PTEN基因的表达缺失可能与肝癌的发生有关;用树鼠句进行肝癌发病学的研究基本上是可行的。 OBJECTIVE: To study the expression of gene PTEN in human and tree shrew heptocellular carcinoma and peritumoral tissues and its relation to invasion and metastasis of liver cancer. METHODS: RT-PCR and immunohistochemistry were employed for the detection of expression of PTEN-mRNA in human heptocellular carcinoma, peritumoral tissues and normal tissues and tree shrew heptocellu lar carcinoma and peritumoral tissues, respectively. RESULTS.. The expression of PTEN-mRNA in human heptocellular carcinoma, peritu moral tissues and normal tissues declined in turn, showing significant differences in statistics (t =0.955, P〈0.001; t = - 10.065, P〈0. 001); whereas that in tree shrew heptocellular carcinoma appeared significant lower level than that in its paratumoral tissues, t=- 3.25, P=0. 004. The expression of PTEN protein in human peritumoral tis sues appeared the significantly higher level than that in human hepto cellular carcinoma,t=-2. 163,P=0. 038; in contrast, no significant difference was found for tree shrew group, t = 0.757, P= 0.459. CONCLUSION: Deficiency in the expression of gene PTEN possibly correlates with hepatocellular carcinogenesis, and it is basically feasible to use tree shrews to study etiology of liver cancer.
出处 《中华肿瘤防治杂志》 CAS 2007年第13期991-993,共3页 Chinese Journal of Cancer Prevention and Treatment
基金 广西应用基础研究专项(0342010-6)
关键词 肝细胞/病理学 磷酸单脂水解酶类/遗传学 基因表达 树鼩属 carcinoma, hepatocellular/pathology phosphoric monoester hydrolases/genetics gene expression tupaia
  • 相关文献

参考文献7

  • 1Steck P A,Pershouse M A,Jasser S A,et al.Identification of candidatetumour suppressor gene,MMAC1,at chromosome 10q23.3 that is mu2tated in multiple advanced cancer[J].Nat Genet,1997,154 (4)∶356-362.
  • 2Slipicevic A,Holm R,Nguyen M T,et al.Expression of activated Akt and PTEN in malignant melanomas:relationship with clinical outcome[J].Am J Clin Pathol,2005,124(4):528-536.
  • 3吕庆杰,赵晓东,宋继谒,李晓晗,马颖,孟辉,姜卫国.卵巢癌PTEN基因失活机制的探讨[J].中华病理学杂志,2005,34(5):266-269. 被引量:15
  • 4Yan R Q,Su J J,Huang D R,et al.Human Hepatitis B virus and hepatocellular carcinoma Ⅱ.Experimental induction of hepatocellular carcinoma in tree shrews exposed to hepatitis B virus and aflatoxin B1[J].J Cancer Res Clin Oncol,1996,122:289-295.
  • 5Whang Y E,Wu X,Suzuki H,et al.Inactivition of t he tumor sup2pressor PTEN/ MMACI in advanced human prostate cancert hrough loss of exprssion[J].Proc Acad Sci USA,1998,95 (9):5246-5250.
  • 6Huang J H,Kontos C D.PTEN modulates vascular endothelial growth factor mediated signaling and angiogenic effects[J].J Biol Chem,2002,277(13):10760-10766.
  • 7万小云,石一复,李娟清.PTEN基因对子宫内膜癌细胞生长的抑制作用[J].中华肿瘤杂志,2004,26(5):275-278. 被引量:7

二级参考文献15

  • 1Sato N, Tsunoda H, Nishida M, et al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res, 2000, 60: 7052-7056.
  • 2Sano T, Lin H, Chen X, et al. Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res, 1999,59:1820-1824.
  • 3Tashiro H, Blazes MS, Wu R, et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res, 1997, 57: 3935-3940.
  • 4Saito M, Okamoto A, Kohno T, et al. Allelic imbalance and mutations of the PTEN gene in ovarian cancer. Int J Cancer, 2000, 85: 160-165.
  • 5Kurose K, Zhou XP, Araki T, et al. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am J Pathol, 2001, 158: 2097-2106.
  • 6Schondorf T, Hoopmann M, Eversheim B, et al. Expression of the tumor suppressor gene PTEN is not altered in the progression of ovarian carcinomas and does not correlate with p27Kip1 expression. Oncol Rep, 2003,10:1717-1722.
  • 7Reis RM, Konu-Lebleblicioglu D, Lopes JM, et al. Genetic profile of gliosarcomas. Am J Pathol, 2000, 156: 425-432.
  • 8Kurose K, Zhou XP, Araki T, et al. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas. Genes Chromosomes Cancer, 2000, 29: 166-172.
  • 9Zhou XP, Gimm O, Hampel H, et al. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Am J Pathol, 2000, 157: 1123-1128.
  • 10Gimm O, Perren A, Weng LP, et al. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol, 2000, 156: 1693-1700.

共引文献20

同被引文献25

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部